Evidence map›Paper›PMID 42227095›Full record

ArticleProblemy endokrinologii2026

[Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children].

A A Dzhamaludinova, L S Sozaeva, N V Makazan, A A Kolodkina, K S Kulikova, N Yu Kalinchenko, A V Bolmasova, E E Novokreshennih, V A Peterkova, N G Mokrysheva

Abstract readEnglish Abstract
In one paragraph

Article in Problemy endokrinologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A A DzhamaludinovaEndocrinology Research Centre.
L S SozaevaEndocrinology Research Centre.
N V MakazanEndocrinology Research Centre.
A A KolodkinaEndocrinology Research Centre.
K S KulikovaEndocrinology Research Centre; Research Center for Medical Genetics; Russian Children's Clinical Hospital, Pirogov RNIMU.
N Yu KalinchenkoEndocrinology Research Centre.
A V BolmasovaEndocrinology Research Centre.
E E NovokreshennihEndocrinology Research Centre.
V A PeterkovaEndocrinology Research Centre.
N G MokryshevaEndocrinology Research Centre.

Funding

Non-US Government Research Support type
6 · The paper itself

Abstract

backgroundHypoparathyroidism (HypoPT) and pseudohypoparathyroidism (PHP) are rare, predominantly genetically determined diseases in children with similar complications, characterized by hypocalcemia and hyperphosphatemia. PHP and HypoPT have similar complications: brain and lens calcification. In HypoPT, there is also an increased risk of developing nephrocalcinosis. Data on the frequency and structure of complications in affected children in Russia are limited, and comparative studies are lacking.

aimTo compare the prevalence of chronic complications and to identify factors associated with their development in children with PHP and congenital forms of HypoPT. MATERIALS AND

methodsA retrospective study with a prospective component included 135 children with PHP and congenital forms of HypoPT. The results of laboratory and instrumental studies were evaluated.

resultsAt least one complication associated with HypoPT/PHP was identified in 82% of children. Nephrocalcinosis was most frequently detected in patients with autoimmune polyendocrine syndrome type 1 (APS-1) (67%) and autosomal dominant hypocalcemia type 1 (ADH1), and much less often in patients with PHP (22%) and unspecified forms of HypoPT (18%). Disease duration, as well as the duration of therapy with active vitamin D analogs and calcium supplements, was significantly longer in patients with nephrocalcinosis (p < 0.001). An association between nephrocalcinosis and cataracts was established (p=0.005). Hypercalciuria persisted in 60% of patients despite medical compensation, was most prevalent in APS-1 and ADH1, and was not observed in PHP (p < 0.001). No statistically significant relationship was identified between hypercalciuria and the development of nephrocalcinosis (p=0.567). A decrease in eGFR corresponding to CKD stage 2 was observed in 48.9% of patients. Fahr's syndrome was detected in 76% of cases, predominantly involving the basal ganglia, and the presence of mineral deposits was associated with hyperphosphatemia (p=0.010). Cataract and micronephrolithiasis were less frequent (18.6% and 3.9%, respectively), with no significant differences between nosological groups. The most common lens opacities observed were cortical (68%) and posterior subcapsular (41%). The duration of the disease was longer in patients with cataracts (p = 0.018).

conclusionAmong the complications observed in children, nephrocalcinosis, hypercalciuria, and Fahr's syndrome were the most frequent. Renal complications predominated in patients with APS-1 and ADH1. Hypercalciuria persisted despite optimal serum calcium levels in most patients.

Indexed as

HypoparathyroidismNephrocalcinosisPseudohypoparathyroidismAdolescentChildChild, PreschoolFemaleHumansHypercalciuriaHyperphosphatemiaHypocalcemiaInfantMaleRetrospective Studies

Identifiers

PMID42227095
PMCPMC13288064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.